ZYME

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 16 M31.03 M27.11 M48.73 M27.61 M 134.48 M Gross profit 16 M31.03 M27.11 M48.73 M27.61 M 134.48 M Operating expenses 16.35 M20.68 M18.6 M18.17 M18.02 M 75.47 M Selling/general/admin expenses 13.85 M16.18 M16.98 M14.95 M14.15 M 62.27 M Research & development 36.35 M37.06 M35.74 M34.45 M35.58 M 142.83 M Operating income 34.2 M22.22 M25.61 M674 K22.11 M 70.61 M Non-Operating Income, Total 204 K-64 K49 K621 K315 K 921 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 167 K-173 K-2 000613 K289 K 727 K Unusual income/expense 37 K109 K51 K8 00026 K 194 K Pretax income 29.62 M17.79 M22.14 M2.13 M18.27 M 60.33 M Equity in earnings ————— — Taxes 226 K5.71 M496 K186 K1.34 M 7.73 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 29.85 M23.51 M22.64 M2.32 M19.6 M 68.06 M Discontinued operations ————— — Net income 29.85 M23.51 M22.64 M2.32 M19.6 M 68.06 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 29.91 M23.05 M22.81 M2.32 M19.77 M 67.95 M Basic earnings per share (Basic EPS) -0.39-0.32-0.30.03-0.26 -0.85 Diluted earnings per share (Diluted EPS) -0.39-0.32-0.30.03-0.26 -0.85 Average basic shares outstanding 76.13 M75.85 M75.17 M75.34 M75.77 M 302.12 M Diluted shares outstanding 76.16 M75.88 M75.23 M77.38 M75.78 M 304.26 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.53 M5.49 M2.6 M4.11 M4.78 M 16.98 M